找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Difficult Decisions in Colorectal Surgery; Neil Hyman,Konstantin Umanskiy Book 20171st edition Springer International Publishing Switzerla

[復(fù)制鏈接]
樓主: rupture
31#
發(fā)表于 2025-3-27 00:12:46 | 只看該作者
32#
發(fā)表于 2025-3-27 02:26:17 | 只看該作者
https://doi.org/10.1007/978-3-642-55732-3 overall median survival in randomized-controlled trials of >20 months [4, 5]; in fact, a recent phase III study suggested that patients who were able to receive all currently available systemic treatment options had a median OS of nearly 30 months [6].
33#
發(fā)表于 2025-3-27 07:06:23 | 只看該作者
34#
發(fā)表于 2025-3-27 11:38:43 | 只看該作者
35#
發(fā)表于 2025-3-27 14:05:56 | 只看該作者
https://doi.org/10.1007/978-3-642-55732-3re powerful techniques for lesion detection become widespread, the detection of dysplasia will likely increase, increasing the relevance of the question ‘What is the most appropriate management of patients with ulcerative colitis and dysplasia?’
36#
發(fā)表于 2025-3-27 18:08:14 | 只看該作者
37#
發(fā)表于 2025-3-28 01:55:58 | 只看該作者
Management of Pouch-Vaginal Fistulasfrom surgery. The optimal management of PVF is not yet determined due to the relative paucity of published data. Most authors agree that the management depends on four basic etiologic/clinical factors: surgery related, sepsis related, disease related, and the location of the fistula.
38#
發(fā)表于 2025-3-28 03:55:29 | 只看該作者
IBD: Management of Dysplasia in Patients with Ulcerative Colitisre powerful techniques for lesion detection become widespread, the detection of dysplasia will likely increase, increasing the relevance of the question ‘What is the most appropriate management of patients with ulcerative colitis and dysplasia?’
39#
發(fā)表于 2025-3-28 08:19:41 | 只看該作者
Stage II Colon Cancer: Towards an Individualized Approache hopes of allowing the practitioner to better risk stratify patients and thereby select those who are most likely to benefit or not benefit from adjuvant chemotherapy. I will conclude with my recommendations for specific cases with the strength of that recommendation based on the science.
40#
發(fā)表于 2025-3-28 12:06:34 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-17 08:16
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
新疆| 香港 | 富平县| 新平| 密云县| 容城县| 肥城市| 古蔺县| 稻城县| 三穗县| 潞西市| 安岳县| 增城市| 晋州市| 格尔木市| 叙永县| 津南区| 罗山县| 北京市| 松潘县| 玉树县| 徐州市| 镇雄县| 大庆市| 邵阳县| 会泽县| 阜平县| 德安县| 崇阳县| 什邡市| 徐闻县| 龙里县| 澄迈县| 察隅县| 南开区| 玛多县| 揭西县| 日照市| 廊坊市| 琼结县| 望江县|